ENTERO THERAPEUTICS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.06 USD | -0.96% |
|
-6.36% | -50.95% |
| 05-20 | Entero Therapeutics, Inc.(NasdaqCM:ENTO) added to NASDAQ Composite Index | CI |
| 05-17 | First Wave BioPharma, Inc. will Change its Name to Entero Therapeutics, Inc | CI |
Chart calendar Entero Therapeutics, Inc.
125c280d3295e4d71729b5a1.F1eUnEXbhC0zHrnla_t8vtmhVvTGqmLrsHS87c6TR8o.dG_m-QaJ3ENfXdqxIsxE1ZzSe5eN7TSKhiHPqKb8foN1AaT3Ipe1S0Vz7A~5c252d85613e548ae58ca5b8faed3425
Upcoming events on Entero Therapeutics, Inc.
No events available
Past events on Entero Therapeutics, Inc.
| 04/06/2024 18:30 | BIO International Convention Conference |
| 19/05/2024 17:30 | Digestive Disease Week Conference - A Composite Mucosal Scale for Celiac Disease |
| 19/05/2024 17:30 | Digestive Disease Week Conference - Dynamics of Serologic Change to Gluten |
| 01/05/2024 19:30 | Planet MicroCap Showcase |
| 01/05/2024 16:30 | Planet MicroCap Showcase |
| 28/04/2024 | Longwood Healthcare Leaders Conference |
| 18/03/2024 17:30 | ROTH Conference |
| 14/03/2024 12:30 | Business Update Call |
| 27/02/2024 18:15 | BIO CEO & Investor Conference |
| 01/02/2024 21:00 | Dealflow Microcap Conference |
| 31/01/2024 15:50 | Dealflow Microcap Conference |
| 29/01/2024 | Dealflow Microcap Conference |
| 24/01/2024 14:30 | Sequire Investor Summit |
| 07/01/2024 | BIO Partnering JPM Week |
| 06/01/2024 16:30 | Longwood Healthcare Leaders CEO Conference |
| 12/12/2023 14:00 | Extraordinary Shareholders Meeting |
| 01/11/2023 | North American Cystic Fibrosis Conference |
| 17/10/2023 19:15 | BIO Investor Forum |
| 12/10/2023 13:15 | Roth Healtcare Opportunities Conference |
| 11/09/2023 12:00 | H.C. Wainwright Global Investment Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,7 -18,0 18.18% | -26,4 -13,3 -98.2% | -59,1 -58,2 -1.43% | -12,7 -13,1 2.96% | -15,8 -15,2 -4.02% | -25,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,2 -18,4 17.63% | -32,7 -21,0 -55.53% | -58,5 -60,2 2.77% | -14,6 -13,9 -5.09% | -15,8 -15,3 -3.28% | -25,4 |
|
Net income Million USD | Released Forecast Spread | -15,2 -18,4 17.32% | -41,7 -23,3 -79.14% | -84,5 -60,1 -40.54% | -14,6 -14,3 -2.31% | -16,1 -15,4 -4.5% | -10,5 |
|
EPS USD | Released Forecast Spread | -28 560 -34 020 16.05% | -48 300 -34 335 -40.67% | -39 774 -29 379 -35.38% | -420 -124 -237.62% | -47,9 -41,5 -15.48% | -1,13 |
| Announcement Date | 30/03/20 | 31/03/21 | 31/03/22 | 20/03/23 | 29/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -9,38 -8,84 -6.18% | -5,41 -8,69 37.81% | 4,39 -3,58 222.61% | -2,28 -2,67 14.51% | -4,06 -2,92 -39.2% | -4,18 -3,40 -22.88% | -3,43 -4,22 18.7% | -4,09 -3,48 -17.51% | -9,23 -4,14 -123.11% | -3,88 | -5,18 | -6,95 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,63 -8,84 -8.95% | -5,41 -8,69 37.79% | 4,39 -3,58 222.66% | -3,99 -2,67 -49.48% | -4,07 -2,92 -39.48% | -4,19 -3,40 -23.1% | -3,43 -4,22 18.68% | -4,10 -3,48 -17.72% | -9,29 -4,14 -124.72% | -3,88 | -5,18 | -6,95 |
|
Net income Million USD | Released Forecast Spread | -10,3 -8,84 -16.71% | -5,55 -8,69 36.13% | 4,23 -3,58 218.26% | -3,99 -2,67 -49.48% | -4,16 -2,92 -42.47% | -4,28 -3,40 -25.88% | -3,48 -4,22 17.51% | -4,18 -3,48 -19.94% | 5,50 -4,14 233.05% | -3,88 | -5,18 | -6,95 |
|
EPS USD | Released Forecast Spread | -2 772 -2 226 -24.53% | -1 050 -1 680 37.5% | 364 -421 186.38% | -189 -8,30 -2181.93% | -36,4 -42,6 14.55% | -37,8 -20,8 -81.73% | -9,20 -11,2 17.86% | -44,7 -4,04 -1008.05% | 0,38 -2,43 115.64% | -1,55 | -0,32 | -0,41 |
| Announcement Date | 23/05/22 | 15/08/22 | 14/11/22 | 20/03/23 | 12/05/23 | 14/08/23 | 13/11/23 | 29/03/24 | 14/05/24 | - | - | - |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Entero Therapeutics, Inc.
| 07/06/2024 07:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ENTO Stock
- Calendar Entero Therapeutics, Inc.